Sarepta Therapeutics, Inc. (SRPT) — Stock Score Summary

Sarepta Therapeutics, Inc. (SRPT) has a MoatMap StockRank of 48/100 based on Quality (50/100), Value (47/100), and Momentum (37/100) factor scores. The current signal is HOLD. Sarepta is a high-risk biotech firm focused on gene therapies; it is not a CDMO and is highly vulnerable to regulatory decisions and high manufacturing costs.

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on developing precision genetic medicines for rare neuromuscular diseases, particularly Duchenne muscular dystrophy (DMD). The company holds a leadership position in DMD therapeutics with multiple approved RNA-targeted and gene therapies, benefiting from strong intellectual property and orphan drug designations. Its specialized pipeline addresses significant unmet medical needs in ultra-rare conditions.

Key Financial Metrics

Price$15.89
Market Cap$1.8B
P/E (TTM)47.60
P/E (Forward)6.11
Price/Book1.17
Return on Equity4.9%
Return on Invested Capital-29.5%
Debt/Equity69.57
Gross Margin-6.5%
Operating Margin49.0%
Revenue Growth-1.9%
Free Cash Flow$205M

Sarepta Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Sarepta Therapeutics, Inc.’s (SRPT) StockRank?
MoatMap’s StockRank for Sarepta Therapeutics, Inc. (SRPT) is 48/100, with a Hold signal. It is a composite of Quality (50), Value (47), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sarepta Therapeutics, Inc. have an economic moat?
Sarepta Therapeutics, Inc. (SRPT) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sarepta Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Sarepta Therapeutics, Inc. (SRPT) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sarepta Therapeutics, Inc. in?
Sarepta Therapeutics, Inc. (SRPT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSRPT deep dive reportAI ChampionsHow we score stocksSense-check another stock